{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:53Z","timestamp":1790610833755,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Febrile neutropenia is a common oncologic emergency that increases the risk for serious infection. This article reviews a joint American Society of Clinical Oncology and Infectious Diseases Society of America guideline for the evaluation and management of patients with cancer who present with fever and neutropenia. Knowledge and use of available risk assessment tools may reduce unnecessary hospitalizations, decrease inappropriate antibiotic use, and improve patient outcomes.<\/jats:p>","DOI":"10.1097\/01.jaa.0000000000000054","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:42:59Z","timestamp":1720554179000},"page":"16-20","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation and management of febrile neutropenia in patients with cancer"],"prefix":"10.1097","volume":"37","author":[{"given":"Jason","family":"Cossey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Claire B.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"issue":"1","key":"R3-20250605","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/acem.14335","article-title":"Association of an emergency department febrile neutropenia intervention protocol with time to initial antibiotic treatment","volume":"29","author":"Seltzer","year":"2022","journal-title":"Acad Emerg Med"},{"issue":"1","key":"R4-20250605","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JOP.18.00269","article-title":"Optimal management of neutropenic fever in patients with cancer","volume":"15","author":"Zimmer","year":"2019","journal-title":"J Oncol Pract"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/978-3-319-74588-6_118","article-title":"Neutropenic fever in the intensive care unit","author":"Stephens","year":"2020","journal-title":"Oncologic Critical Care"},{"issue":"2","key":"R6-20250605","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/TME.0000000000000399","article-title":"Review of hematological and oncological emergencies","volume":"44","author":"Barr\u00e9","year":"2022","journal-title":"Adv Emerg Nurs J"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajem.2021.07.008","article-title":"Emergency department management of chemotherapy related febrile neutropenia: an opportunity to improve care","volume":"50","author":"Pettit","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"6","key":"R8-20250605","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/1078155219896396","article-title":"Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: is there room for improvement","volume":"26","author":"Jansma","year":"2020","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"R9-20250605","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/ash.2022.353","article-title":"Going local: evaluating guideline adherence and appropriateness of antibiotic prescribing in patients with febrile neutropenia at an academic teaching hospital","volume":"3","author":"Liu","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"5","key":"R10-20250605","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1177\/10781552221092158","article-title":"Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: an observational study in a referral center in Iran","volume":"29","author":"Ekhtiari Kolour","year":"2023","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"R11-20250605","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/1078155219896396","article-title":"Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: is there room for improvement","volume":"26","author":"Jansma","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijregi.2021.09.002","article-title":"Mortality-associated clinical risk factors in patients with febrile neutropenia: a retrospective study","volume":"1","author":"Sereeaphinan","year":"2021","journal-title":"IJID Reg"},{"issue":"5","key":"R13-20250605","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jemermed.2019.08.009","article-title":"Oncologic emergencies: the fever with too few neutrophils","volume":"57","author":"Long","year":"2019","journal-title":"J Emerg Med"},{"issue":"14","key":"R14-20250605","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3","key":"R15-20250605","doi-asserted-by":"crossref","first-page":"e0014","DOI":"10.5041\/RMMJ.10501","article-title":"The risk of rectal temperature measurement in neutropenia","volume":"14","author":"Olchowski","year":"2023","journal-title":"Rambam Maimonides Med J"},{"issue":"8","key":"R16-20250605","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/medicina58080985","article-title":"Procalcitonin as a predictive tool for death and ICU admission among febrile neutropenic patients visiting the emergency department","volume":"58","author":"Coyne","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"23","key":"R17-20250605","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1002\/cam4.4355","article-title":"The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: a useful alternative to the multinational association for supportive care in cancer score","volume":"10","author":"Chaftari","year":"2021","journal-title":"Cancer Med"},{"issue":"6","key":"R18-20250605","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s40121-022-00700-1","article-title":"The Dutch Working Party on Antibiotic Policy (SWAB) recommendations for the diagnosis and management of febrile neutropenia in patients with cancer","volume":"11","author":"de la Court","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"2","key":"R20-20250605","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00520-020-05906-y","article-title":"Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper","volume":"29","author":"Cooksley","year":"2021","journal-title":"Support Care Cancer"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2147\/CMAR.S348923","article-title":"Management of treatment-related infectious complications in high-risk hemato-oncological patients via telemedicine","volume":"14","author":"Hradsk\u00e1","year":"2022","journal-title":"Cancer Manag Res"},{"issue":"7","key":"R22-20250605","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac240","article-title":"Bloodstream infections in hematologic malignancy patients with fever and neutropenia: are empirical antibiotic therapies in the United States still effective","volume":"9","author":"Zimmer","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"R23-20250605","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cmi.2017.03.024","article-title":"Comparison of antipseudomonal \u03b2-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis","volume":"23","author":"Horita","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"R24-20250605","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac079","article-title":"A prospective randomized study comparing ceftolozane\/tazobactam to standard of care in the management of neutropenia and fever in patients with hematological malignancies","volume":"9","author":"Chaftari","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"R25-20250605","doi-asserted-by":"crossref","first-page":"101355","DOI":"10.1016\/j.disamonth.2022.101355","article-title":"An updated narrative review on the management of the most common oncological and hematological emergencies","volume":"69","author":"Issani","year":"2023","journal-title":"Dis Mon"},{"issue":"12","key":"R26-20250605","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial","volume":"4","author":"Aguilar-Guisado","year":"2017","journal-title":"Lancet Haematol"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000000000000054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:01:47Z","timestamp":1749153707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000000000000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000000000000054","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}